RedHill Biopharma Ltd Announces Concerning Clarithromycin Rx Rates for H. pylori
RedHill Biopharma: Concerning Rates of Clarithromycin Prescribing for H. pylori, Despite Increasing Antibiotic Resistance, Uncovered in New Digestive Diseases &...
News
Panacea Life Sciences, Inc. establishes a presence in Brazil as early as January 2022
GOLDEN, CO / ACCESSWIRE / December 9, 2021 / Panacea Life Sciences, Inc. (OTCQB:PLSH), (the "Company"), a cGMP certified, vertically...
INmune Bio, Inc. Announces Key Breast Cancer Treatment Resistance Data to be Presented at the 2021 San Antonio Breast Cancer Symposium
Data suggests in triple negative breast cancer that MUC4 predicts survival and resistance to immunotherapy and that INB03 reverses resistance...
Albireo Announces Changes to R&D Organization
BOSTON, Dec. 09, 2021 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (Nasdaq: ALBO), a rare liver disease company developing novel bile...
adyn Wins Two Prestigious Industry Healthcare Awards
adyn named to the 2021 CB Insights Digital Health 150 and Founder and CEO, Elizabeth Ruzzo awarded Rock Health’s Top...
BriaCell Summarizes Clinical Data Poster Presented at the 2021 San Antonio Breast Cancer Symposium®
NEW YORK and VANCOUVER, British Columbia, Dec. 09, 2021 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX-V:BCT) (“BriaCell”...
Scilex Holding Company, a Sorrento Therapeutics, Inc. Subsidiary, Announces Highly Significant Positive Top-Line Results from its Phase 3 Non-Opioid Injectable SP-102 (SEMDEXA™) Pivotal Trial C.L.E.A.R. Program for Sciatica Pain Management Supporting the Potential Use of SP-102 as a Best-in-Class Therapy
Scilex Holding Company, a commercial-stage, non-opioid biopharmaceutical pain management company, announces highly significant positive top-line results from its Phase 3...
Block Society Co-Founder Faris Khan Executes Launch of Automated COVID-19 Screening Solution “IHS Screening” at ISNA High School in Mississauga, ON
Picture 1 Faris Khan, age 17, co-founded Block Society at ISNA High School in 2021 as an initiative for making...
Carrot Fertility Expands Executive Team, Hires Former Aetna Executive as Chief Commercial Officer
The leading global fertility and family-forming benefits provider creates new chief officer roles to position the company for continued growthMENLO...
BioCorRx Appoints Drug Delivery Expert Jie Shen, Ph.D., to Scientific Advisory Board
ANAHEIM, CA, Dec. 09, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer and...
First Stop Health Enhances Executive Team as Virtual Care Provider Growth Continues
The three additions to the executive team at FSH will aid in the growth of its Telemedicine, Virtual Mental Health...
Clover Health Launches New Clinical Program Targeting Chronic Kidney Disease in Partnership with Cricket Health
The Clover Assistant synthesizes health data and surfaces personalized clinical recommendations to physicians to drive earlier disease detection and interventionSpecialty...
Cannabix Technologies To Present at Texas Impaired Driving Forum, Provides Corporate Update
Cannabix is developing Marijuana Breathalyzer devices to give law enforcement and employers a tool to enhance public safetyVANCOUVER, British Columbia,...
Allied Colombia Exceeds the 120th Employee Milestone in Its Company Growth Trajectory
KELOWNA, British Columbia, Dec. 09, 2021 (GLOBE NEWSWIRE) -- Allied Corp. ("Allied" or the “Company”) (OTCQB: ALID) is pleased to...
Berkeley Lights to Showcase its Optofluidic Discovery Technology at 2021 Antibody Engineering & Therapeutics Conference
Genovac, a top contract research and manufacturing organization, to report new single B-cell service offerings and GPCR campaign results achieved...
ABVC BioPharma Introduces Dietary Supplement Based on Maitake Mushroom, Enters into $3.0 Million Distribution Agreement
Fremont, CA, Dec. 09, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- ABVC Biopharma, Inc. (NASDAQ: ABVC), a clinical stage biopharmaceutical company developing...
Acer Therapeutics Announces ACER-801 IND Clearance for the Treatment of Induced Vasomotor Symptoms
Phase 2a trial initiation expected in Q1 2022 Trial designed to generate proof of concept data for ACER-801 and identify...
Mustang Bio to Host Key Opinion Leader Webinar on MB-106, a Potential Treatment for B-Cell Non Hodgkin Lymphomas and Chronic Lymphocytic Leukemia
Webinar to be held on Thursday, December 16, 2021, at 2:30 p.m. ET WORCESTER, Mass., Dec. 09, 2021 (GLOBE NEWSWIRE)...
Pyxis Oncology Appoints Martina Molsbergen as Interim Chief Business Officer
Industry veteran brings expertise in corporate strategy and business development to Pyxis teamCAMBRIDGE, Mass., Dec. 09, 2021 (GLOBE NEWSWIRE) --...
Vir Biotechnology Announces Initiation of Phase 2 Clinical Trial Evaluating VIR-2218, Selgantolimod and Nivolumab for the Treatment of Chronic Hepatitis B Virus Infection
– Trial to evaluate antigen suppression combined with immunomodulation as a functional cure regimen for chronic HBV – SAN FRANCISCO,...